Member Groups

Value & Access

Overview

The Value and Access group is the combined Commercial Policy group and Market Access Policy group. It brings together our work on the adoption and spread of innovation and the commercial uptake by the NHS, while allowing the specific needs of market access and procurement to be addressed. The objective of the group is to ensure that the NHS takes a value-based approach to the assessment, adoption and procurement of health technologies across the system.

Leadership 
  • Chair (Market Access Group) - Kieran Murphy, ReCor Medical UK
  • Vice Chairs (Market Access Group) - Mark Chapman, Medtronic & Richard Evans, WL Gore & Steve Fearn, Abbott     
  • Chair (Commercial Policy Group) - Graeme Cameron, B, Braun
Achievements    

Commercial

  • Delivered paper to Ministers on procurement landscape and 10 recommendations for the future requirements of NHS procurement.
  • Created key commercial messages and led engagement with NHS Supply Chain on critical issues.
  • Collated examples of innovations used to support the NHS during the COVID-19 crisis, which were shared with NICE, the Accelerated Access Collaborative and NHS Wales Value Based Procurement.

Market Access

  • Delivered ABHI Paper to NICE on critical aspects for inclusion in the Methods and Process Review.
  • Group members provided input to the NICE Methods and Process Review Task & Finish groups ensuring sector voice taken into account. The Case for Change consultation included points provided by members.
  • Provided critical feedback on the MedTech Funding Mandate Policy to instigate change in the requirement for in-year savings.
Priorities

Strategic Commercial – Value not Price

  • End era of NHS policy of zero inflation, as it is no longer sustainable after 10 years, using developed costs to serve data.
  • Engage with the royal colleges, Getting it Right Frist Time and NHS England clinical teams to increase expertise and knowledge of value-based healthcare.
  • Embed value-based procurement (VBP) and support training of NHS procurement and Category Towers of VBP, including through collaboration with the NHS Supply Chain VBP work.

SCCL Operational Engagement

  • Deliver the developed key messages in any engagement with Supply Chain Coordination Limited and Category Towers.
  • Through quarterly members survey and quarterly meetings with NHS Supply Chain, create a solution orientated approach to partnership working with NHS Supply Chain and Category Towers.
  • Building on the 10 recommendations for change collated from suppliers, drive improved processes for planning and responding to future pandemics.

NICE Methods and Process Review

  • Deliver sector requirements through consultation responses to the Methods manual and Process review.
  • Develop the ‘Accelerated Transitional Access Scheme’ through work with NICE, the Accelerated Access Collaborative and the Health Technology Partnership.

Accelerated Access Collaborative

  • Ensure the voice of HealthTech is strongly represented in all key Accelerated Access Collaborative programmes, and following the re-start of MedTech Funding Mandate Policy and Rapid Uptake Products shape policy for future iterations.
  • Drive the Accelerated Access Collaborative to focus on landscape, not just identified cohort of products.
  • Develop the ‘Accelerated Transitional Access Scheme’ through work with NICE, the Accelerated Access Collaborative and the Health Technology Partnership.
Useful Resources 

Click here to view the latest updates, minutes and future meeting dates for the group. 

 

“During these most challenging of times the support of the ABHI has never been more critical. The Value & Access group is a group of like-minded suppliers to the NHS who are passionate about ensuring that the correct quality and access to medical technology is provided for the benefit of all patients. Despite the coronavirus crisis we have never stopped in trying to push forward with this vision driven by constant dialogue with Supply Chain Coordination Limited to deliver operational equity, while delivering on the ultimate goal of ensuring that value-based procurement and healthcare become the bedrock of NHS procurement.
Graeme Cameron, CEO, Pennine Healthcare & Chair, ABHI Commercial

“Covering the way health technologies are assessed, commissioned and hospitals reimbursed, market access is critical to commercial success of ABHI members. The Market Access group works to ensure the NHS enables timely access to benefit patients and the wider health system. In an ever-changing landscape, it is critical that the health technology industry works effectively with Government and the NHS to realise these benefits and remove barriers which work against achieving the best patient outcomes within an efficient health system across the UK.
Kieran Murphy, Senior Director, Market Access, ReCor Medical UK & Chair, ABHI Market Access